MedPlus announces the suspension of a drug license for one of its stores in Telangana. The suspension, effective from January 29, 2026, is related to a violation under the Drugs and Cosmetics Act. The potential revenue loss due to this suspension is estimated at Rs 0.20 lacs. The company is taking steps to ensure compliance and minimize disruption.
Telangana Store License Suspended
A drug license for one of MedPlus’s stores in Telangana has been suspended for one day. This decision arises from an order received on January 29, 2026, by the Assistant Director, Drugs Control Administration, Patancheru, Telangana.
Details of the Suspension
The suspension pertains to a store located at Kardanur Patancheru Shankarpalli Road, Telangana. The action was taken under Rule 66(1) of the Drugs and Cosmetics Act, 1940, and Drugs and Cosmetics Rules, 1945.
Financial Impact
The company estimates a potential revenue loss of Rs 0.20 lacs because of the temporary suspension. MedPlus is working to address the matter.
Source: BSE
